| First Author | Osokine I | Year | 2022 |
| Journal | Cell Rep | Volume | 38 |
| Issue | 5 | Pages | 110329 |
| PubMed ID | 35108527 | Mgi Jnum | J:322644 |
| Mgi Id | MGI:6879579 | Doi | 10.1016/j.celrep.2022.110329 |
| Citation | Osokine I, et al. (2022) Gene silencing by EZH2 suppresses TGF-beta activity within the decidua to avert pregnancy-adverse wound healing at the maternal-fetal interface. Cell Rep 38(5):110329 |
| abstractText | A little-appreciated feature of early pregnancy is that embryo implantation and placental outgrowth do not evoke wound-healing responses in the decidua, the specialized endometrial tissue that surrounds the conceptus. Here, we provide evidence that this phenomenon is partly due to an active program of gene silencing mediated by EZH2, a histone methyltransferase that generates repressive histone 3 lysine 27 trimethyl (H3K27me3) histone marks. We find that pregnancies in mice with EZH2-deficient decidual stromal cells frequently fail by mid-gestation, with the decidua showing ectopic myofibroblast formation, peri-embryonic collagen deposition, and gene expression profiles associated with transforming growth factor beta (TGF-beta)-driven fibroblast activation and fibrogenic extracellular matrix (ECM) remodeling. Analogous responses are observed when the mutant decidua is surgically wounded, while blockade of TGF-beta receptor signaling inhibits the defects and improves reproductive outcomes. Together, these results highlight a critical feature of reproductive success and have implications for the context-specific control of TGF-beta-mediated wound-healing responses elsewhere in the body. |
